Gaoma Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$703K
- Investors
-
10
Gaoma Therapeutics General Information
Description
Developer of therapeutic molecules designed to address unmet medical needs in neurological or inflammatory diseases. The company focuses on particular expertise in the fields of epilepsy and cognitive disorders and offers a portfolio of innovative lipid derivatives as drug candidates, enabling healthcare organizations to offer essential medicine to their patients.
Contact Information
Website
www.gaoma-tx.comCorporate Office
- Institut Des Epilepsies-Europe
- 59 Boulevard Pinel
- 69500 Lyon
- France
Corporate Office
- Institut Des Epilepsies-Europe
- 59 Boulevard Pinel
- 69500 Lyon
- France
Gaoma Therapeutics Timeline
Gaoma Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 21-Aug-2024 | $703K | Completed | Generating Revenue | ||
| 4. Debt - General | 27-Apr-2023 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-May-2022 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 01-Apr-2021 | $1.32M | $1.32M | Completed | Pre-Clinical Trials | |
| 1. Grant | $98.9K | Completed | Pre-Clinical Trials |
Gaoma Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| A Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Gaoma Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gaoma Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gaoma Therapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bpifrance | Sovereign Wealth Fund | |||
| 4Fish | Corporation | Minority | ||
| Angelor | Venture Capital | Minority | ||
| Angels Santé | Angel Group | Minority | ||
| Compagnie Financière de Participation | PE-Backed Company | Minority |
Gaoma Therapeutics FAQs
-
When was Gaoma Therapeutics founded?
Gaoma Therapeutics was founded in 2019.
-
Where is Gaoma Therapeutics headquartered?
Gaoma Therapeutics is headquartered in Lyon, France.
-
What is the size of Gaoma Therapeutics?
Gaoma Therapeutics has 6 total employees.
-
What industry is Gaoma Therapeutics in?
Gaoma Therapeutics’s primary industry is Drug Discovery.
-
Is Gaoma Therapeutics a private or public company?
Gaoma Therapeutics is a Private company.
-
What is the current valuation of Gaoma Therapeutics?
The current valuation of Gaoma Therapeutics is .
-
What is Gaoma Therapeutics’s current revenue?
The current revenue for Gaoma Therapeutics is .
-
How much funding has Gaoma Therapeutics raised over time?
Gaoma Therapeutics has raised $2.51M.
-
Who are Gaoma Therapeutics’s investors?
Bpifrance, 4Fish, Angelor, Angels Santé, and Compagnie Financière de Participation are 5 of 10 investors who have invested in Gaoma Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
